Journal
ANALYTICAL AND BIOANALYTICAL CHEMISTRY
Volume 388, Issue 7, Pages 1455-1465Publisher
SPRINGER HEIDELBERG
DOI: 10.1007/s00216-007-1228-9
Keywords
in utero; drug testing; cord blood; meconium; umbilical cord; prenatal drug exposure
Funding
- Intramural NIH HHS [Z01 DA000412-10, Z01 DA000433-08] Funding Source: Medline
Ask authors/readers for more resources
Drug use by pregnant women has been extensively associated with adverse mental, physical, and psychological outcomes in their exposed children. This manuscript reviews bioanalytical methods for in utero drug exposure monitoring for common drugs of abuse in urine, hair, oral fluid, blood, sweat, meconium, amniotic fluid, umbilical cord tissue, nails, and vernix caseosa; neonatal matrices are particularly emphasized. Advantages and limitations of testing different maternal and neonatal biological specimens including ease and invasiveness of collection, and detection time frames, sensitivities, and specificities are described, and specific references for available analytical methods included. Future research involves identifying metabolites unique to fetal drug metabolism to improve detection rates of in utero drug exposure and determining relationships between the amount, frequency, and timing of drug exposure and drug concentrations in infant biological fluids and tissues. Accurate bioanalytical procedures are vital to defining the scope of and resolving this important public health problem.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available